Dual agonist · GLP-1 / GIP

Tirzepatide

$95 30 mg · per vial
1
For research use only. Not for human consumption.
Route
Subcutaneous
Documentation
On request
Shipping
Discreet
Handling
Inspected on arrival

A dual agonist at the GLP-1 and GIP receptors. Studied for its role in appetite regulation, gastric emptying, and glucose-dependent insulin secretion — the dual-receptor mechanism behind its FDA-approved analogs.

Watch
Deep research

Mechanism, common research protocols, evidence review, and cited primary literature for Tirzepatide live on the full guide.

Read the guide →